MIT, Broad scientists overcome key CRISPR-Cas9 genome editing hurdle
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
With a new DARPA contract, biological engineer Christopher Voigt aims to harness the power of living cells.
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Study of epigenomic modifications reveals immune basis of Alzheimer's disease.
11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.
Three neuroscientists at MIT have been selected to receive awards from the Society for Neuroscience.
In Compton Lecture, NIH director details the importance of reaching out to others.
Time-saving tool takes advantage of CRISPR gene-editing technology.
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
NIH-sponsored work to characterize genetic variation in human tissues with roles in diabetes, heart disease, and cancer.
Transformative partnership with Ted Stanley will spur researchers to reveal biology of psychiatric disorders.